TGIWX
Price
$16.09
Change
-$0.12 (-0.74%)
Updated
Aug 19 closing price
Net Assets
7.32B
VSTSX
Price
$301.61
Change
-$1.84 (-0.61%)
Updated
Aug 19 closing price
Net Assets
1.91T
Interact to see
Advertisement

TGIWX vs VSTSX

Header iconTGIWX vs VSTSX Comparison
Open Charts TGIWX vs VSTSXBanner chart's image
Nuveen Core Equity W
Price$16.09
Change-$0.12 (-0.74%)
VolumeN/A
Net Assets7.32B
Vanguard Total Stock Mkt Idx Instl Sel
Price$301.61
Change-$1.84 (-0.61%)
VolumeN/A
Net Assets1.91T
TGIWX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TGIWX vs. VSTSX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGIWX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. TGIWX (7.32B). TGIWX pays higher dividends than VSTSX: TGIWX (1.29) vs VSTSX (1.20). TGIWX was incepted earlier than VSTSX: TGIWX (7 years) vs VSTSX (9 years). TGIWX (0.40) is less costly to investors than VSTSX (0.01). TGIWX is a more actively managed with annual turnover of: 25.00 vs. VSTSX (2.00). TGIWX has a lower initial minimum investment than VSTSX: TGIWX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 16.03 vs. TGIWX (4.74). VSTSX return over 5 years is better than : 85.70 vs. TGIWX (10.86).
TGIWXVSTSXTGIWX / VSTSX
Total Expense Ratio0.000.01-
Annual Report Gross Expense Ratio0.400.014,000%
Fund Existence7 years9 years-
Gain YTD8.3499.32490%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.32B1.91T0%
Annual Yield % from dividends1.291.20108%
Returns for 1 year4.7416.0330%
Returns for 3 years13.9150.0128%
Returns for 5 years10.8685.7013%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KVYO32.020.59
+1.88%
Klaviyo
VSCO22.720.38
+1.70%
Victoria's Secret & Co
CYCCP5.91N/A
N/A
Cyclacel Pharmaceuticals
LE12.80-0.14
-1.08%
Lands' End
OVID0.93-0.04
-3.84%
Ovid Therapeutics